Characteristics of the treatment of perennial allergic rhinitis in patients of the older age group
Recent studies show that perennial allergic rhinitis is prevalent among older people, but the management of this disease is underestimated and not determined. This article describes the persistent allergic rhinitis in patients of the older age group and identifies the primary goals of treatment base...
| Main Authors: | , |
|---|---|
| Format: | Article |
| Language: | Russian |
| Published: |
Remedium Group LLC
2018-11-01
|
| Series: | Медицинский совет |
| Subjects: | |
| Online Access: | https://www.med-sovet.pro/jour/article/view/2783 |
| _version_ | 1797841499859189760 |
|---|---|
| author | K. I. Sapova S. V. Ryazantsev |
| author_facet | K. I. Sapova S. V. Ryazantsev |
| author_sort | K. I. Sapova |
| collection | DOAJ |
| description | Recent studies show that perennial allergic rhinitis is prevalent among older people, but the management of this disease is underestimated and not determined. This article describes the persistent allergic rhinitis in patients of the older age group and identifies the primary goals of treatment based on the age-related physiological factors, concomitant conditions and the use of other drugs. Special attention is paid to the various options for the drug therapy in elderly patients over the age of 60 years. The second-generation antihistamines and intranasal glucocorticosteroids also have primacy over other drugs, when supervising older patients. A randomized open multicenter clinical study showed that Momate Rhino Advance (a combination of intranasal antihistamines (azelastine) and intranasal glucocorticosteroids (mometasone) for the treatment of allergic rhinitis) made by Indian Glenmark Pharmaceuticals Ltd. is effective and safe in patients aged 60 years and older, who are diagnosed with the above disease. |
| first_indexed | 2024-04-09T16:31:49Z |
| format | Article |
| id | doaj.art-688649453f45402db4d8eb40015e0d2e |
| institution | Directory Open Access Journal |
| issn | 2079-701X 2658-5790 |
| language | Russian |
| last_indexed | 2024-04-09T16:31:49Z |
| publishDate | 2018-11-01 |
| publisher | Remedium Group LLC |
| record_format | Article |
| series | Медицинский совет |
| spelling | doaj.art-688649453f45402db4d8eb40015e0d2e2023-04-23T06:57:04ZrusRemedium Group LLCМедицинский совет2079-701X2658-57902018-11-0102010711010.21518/2079-701X-2018-20-107-1102725Characteristics of the treatment of perennial allergic rhinitis in patients of the older age groupK. I. Sapova0S. V. Ryazantsev1Saint-Petersburg Research Institute of Ear, Throat, Nose and Speech of the Ministry of Health of Russia, St. PetersburgSaint-Petersburg Research Institute of Ear, Throat, Nose and Speech of the Ministry of Health of Russia, St. PetersburgRecent studies show that perennial allergic rhinitis is prevalent among older people, but the management of this disease is underestimated and not determined. This article describes the persistent allergic rhinitis in patients of the older age group and identifies the primary goals of treatment based on the age-related physiological factors, concomitant conditions and the use of other drugs. Special attention is paid to the various options for the drug therapy in elderly patients over the age of 60 years. The second-generation antihistamines and intranasal glucocorticosteroids also have primacy over other drugs, when supervising older patients. A randomized open multicenter clinical study showed that Momate Rhino Advance (a combination of intranasal antihistamines (azelastine) and intranasal glucocorticosteroids (mometasone) for the treatment of allergic rhinitis) made by Indian Glenmark Pharmaceuticals Ltd. is effective and safe in patients aged 60 years and older, who are diagnosed with the above disease.https://www.med-sovet.pro/jour/article/view/2783persistent (perennial) allergic rhinitispatients of the older age groupcombination drugspray momate rhino advance |
| spellingShingle | K. I. Sapova S. V. Ryazantsev Characteristics of the treatment of perennial allergic rhinitis in patients of the older age group Медицинский совет persistent (perennial) allergic rhinitis patients of the older age group combination drug spray momate rhino advance |
| title | Characteristics of the treatment of perennial allergic rhinitis in patients of the older age group |
| title_full | Characteristics of the treatment of perennial allergic rhinitis in patients of the older age group |
| title_fullStr | Characteristics of the treatment of perennial allergic rhinitis in patients of the older age group |
| title_full_unstemmed | Characteristics of the treatment of perennial allergic rhinitis in patients of the older age group |
| title_short | Characteristics of the treatment of perennial allergic rhinitis in patients of the older age group |
| title_sort | characteristics of the treatment of perennial allergic rhinitis in patients of the older age group |
| topic | persistent (perennial) allergic rhinitis patients of the older age group combination drug spray momate rhino advance |
| url | https://www.med-sovet.pro/jour/article/view/2783 |
| work_keys_str_mv | AT kisapova characteristicsofthetreatmentofperennialallergicrhinitisinpatientsoftheolderagegroup AT svryazantsev characteristicsofthetreatmentofperennialallergicrhinitisinpatientsoftheolderagegroup |